Latest News: KGMU prof suspended for forcing patients to buy meds from pvt storeWorld Record in Robotic Tele-Surgery takes Intercontinental Leap of 20,000 KmCDSCO receives 1,387 adverse drug reaction reports in nine months of 2025NGT issues notice to Himachal pharma unit over pollution, water diversion allegationsZydus Semaglutide approval: Delhi HC directs CDSCO to decide on patient safety concernsDGFT Fixes Six New Standard Input Output Norms (SIONs) for Pharmaceutical and Chemical ExportsNurse, another arrested in ASHA worker’s death at illegal hospital; main accused at largeKGMU to file FIR against 4 employees over Rs 2.5 crore medicine procurement irregularitiesHaryana Launches ‘Make in Haryana Industrial Policy’A new pancreatic cancer pill may be a game changer for patientsNPPA fixes prices of 30 drugs including Vitamin D3, calcium supplementsMaharashtra FDA seizes ₹73 lakh worth of medicines in crackdown on misleading health claims in adsIndustry asks NPPA to implement SOTS Scheme to resolve pending litigationsA Non- Smoker Smoking Hot Spouse needed for Actress Neetu ChandraGene Therapy for Cholesterol: Initial Test Results CheerUS Biotech Regeneron to launch Global Capability Centre in HyderabadPopped the Pill, Paid the Price to Potentially Fatal Skin SyndromeFormer Advisor to India’s Union Health Ministry gets Quite a Feather in his CapAlembic Pharma Secures USFDA Approval for Generic Synthroid TabletsSTF busts fake meds racket spread across 6 statesAll the Way from Teeth to Tee: Hole in OneZydus Lifesciences Q4FY26 net profit rises 9%Chemists strike on May 20: Reasons behind today’s all-India strikeAbbVie loses patent plea for Hep C drugGSK’s Calpol a well-known trademark: High Court3 arrested for allegedly posing as doctors using forged MBBS degreesCommissioner FDA reviews enforcement measuresKarnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplementsRoche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancerCDSCO tighten drug quality oversight as substandard and spurious medicine cases rise in five yearsPiramal Pharma Gets 3 USFDA Observations at US FacilityEli Lilly pauses Indian obesity awareness campaign after regulatory noticesKota: Uproar After 4 Women Die in Government Hospital; Relatives Refuse to Take BodiesICMR transfers three Indigenous Medical Technologies to Industry at National Technology Day 2026Will ‘Epidemic’ of Bridge Collapse in Bihar halt with new Minister in?Patient dies after oxygen supply stops in ambulanceIndiaAI, ICMR sign MoU to advance AI in healthcareIllegal drug manufacturing racket busted in Baddi areaUS FDA and Telangana DCA bolster global pharma safety at second regulatory forumNishant as Health Minister, Bihar is all set to witness a New Dawn of HealthcareSix Women Develop Serious Complications After C-SectionCracks Down on Pharma Biological Firm in Bagru; Labeling Violations, Unapproved Claims and Quality Lapses DetectedIndian Pharma Majors Plan to Invest in USEmcure Pharmaceuticals Q4 net profit rises 24% to ₹243.74 crFake Cancer Drug Racket: Delhi HC Grants Bail, Flags Gaps in ED ProbeA SSi Mantra fame Robotic Telesurgery Champion pulls off another Spectacular IntercontinentalNational Pharmaceutical Pricing Authority notifies retail price of 42 new drugsWorld’s First Malaria Treatment for Newborns and Young Infants Receives WHO PrequalificationFIR Lodged Against Pharmacist in Chandauli for Working Nearly 10 Years on Forged DocumentsLaughing all the Way to Health with Sir Ganga Ram HospitalSemaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik JonssonPak-made illegal cosmetics recovered from Itwari shopLicences of 20 medical stores suspended after inspectionsBain Capital sells nearly 1 pc stake in Emcure Pharma for Rs 289 croreSun Pharma to acquire U.S. firm Organon in $11.75 billion dealHP accounts for 47 inferior drugs in March alertCivil society group SAM calls for greater transparency involving clinical trialsDifferent packaging, typos expose fake Mounjaro racketTo Eat or not to Eat, if this Dilemma is ‘Eating’ you, ‘Eat’ this BookNCB Hyderabad raids illegal lab, seizes 69 kg of Alprazolam worth Rs 17.4 croreRajasthan Bans 7 Sub-Standard MedicinesONESOURCE’s partner receives USFDA tentative approval for Semaglutide InjectionAjanta Pharma gets USFDA Form 483 with five observations at Paithan plantObesity drug market to gain as Indians pop the pill and Chinese bring moreAurobindo Pharma Rs 800 Cr Buyback Opens Apr 23Boehringer Ingelheim launches AI centre for pharma research in LondonPharma exports rose 2% to over $31 billion in FY26 despite sharp decline in MarchCentre Urges States To Enforce Clinical Establishments Act & Standardise Hospital RatesPiramal, Ajinomoto team on ADC development and manufacturingAurobindo Pharma Gets USFDA Nod for Glycerol LiquidCancer cure must not be hostage to Big PharmaGLP-1 drugs emerge as a new option for Indian women bat­tling PCOSAurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral LiquidLegal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In IndiaPatna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS ActCOMT Inhibitors May Fuel Gut Bacteria That Degrade Levodopa In Parkinson’s PatientsDelhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One ArrestedFDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug DevelopmentIPC releases draft NFI-2026 to promote rational use of medicinesMoonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic SurgeryUS market to dent India pharma earnings even as domestic growth remains firmBiocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mgHealthcare, pharma sector to create 2-2.5 million new jobs by 2030Over 45% eye infection bacteria drug-resistant, study flags AMR threatLokayukta Police Launch Multi-City Raids on ADC; Rs 3.37 Crore in Disproportionate Assets Unearthed Across KarnatakaAlembic Pharma Gets USFDA Nod for DapagliflozinOn World Health Day ‘CAHO Na Patient Se Pyaar Hai’Supreme Court willing to understand Angst of Doctors regarding Consumer Protection ActAurobindo Pharma Board approves ₹800 cr share buyback planThree held for cheating SCB Hospital patients on promise of arranging bloodNATHEALTH resolves to evolve to fit The Bill of Viksit BharatCancer drug makers seek 50% price hike as platinum surge hits production viabilityCDRI’s new research hub in Lucknow to facilitate innovation in drug discovery & developmentDelhi Police busts racket diverting govt-supplied medicines for private sale; 3 heldNiti Aayog & DPIIT Decriminalize Med Device Penalties for Ease of BusinessLaser rescued an Imperiled Food Pipe in Sir Ganga Ram HospitalCentre gives custom cushion to supply strained Pharma, MedTech manufacturersDelhi man arrested for running online racket selling counterfeit Ayurvedic productsCustoms Duty Exemption on Petrochemicals, AiMeD welcomes but Dil ‘Mange More’Sir Ganga Ram Hospital Launches Dialysis Center in Gurgaon for advanced care
June 6, 2026
Latest News: KGMU prof suspended for forcing patients to buy meds from pvt storeWorld Record in Robotic Tele-Surgery takes Intercontinental Leap of 20,000 KmCDSCO receives 1,387 adverse drug reaction reports in nine months of 2025NGT issues notice to Himachal pharma unit over pollution, water diversion allegationsZydus Semaglutide approval: Delhi HC directs CDSCO to decide on patient safety concernsDGFT Fixes Six New Standard Input Output Norms (SIONs) for Pharmaceutical and Chemical ExportsNurse, another arrested in ASHA worker’s death at illegal hospital; main accused at largeKGMU to file FIR against 4 employees over Rs 2.5 crore medicine procurement irregularitiesHaryana Launches ‘Make in Haryana Industrial Policy’A new pancreatic cancer pill may be a game changer for patientsNPPA fixes prices of 30 drugs including Vitamin D3, calcium supplementsMaharashtra FDA seizes ₹73 lakh worth of medicines in crackdown on misleading health claims in adsIndustry asks NPPA to implement SOTS Scheme to resolve pending litigationsA Non- Smoker Smoking Hot Spouse needed for Actress Neetu ChandraGene Therapy for Cholesterol: Initial Test Results CheerUS Biotech Regeneron to launch Global Capability Centre in HyderabadPopped the Pill, Paid the Price to Potentially Fatal Skin SyndromeFormer Advisor to India’s Union Health Ministry gets Quite a Feather in his CapAlembic Pharma Secures USFDA Approval for Generic Synthroid TabletsSTF busts fake meds racket spread across 6 statesAll the Way from Teeth to Tee: Hole in OneZydus Lifesciences Q4FY26 net profit rises 9%Chemists strike on May 20: Reasons behind today’s all-India strikeAbbVie loses patent plea for Hep C drugGSK’s Calpol a well-known trademark: High Court3 arrested for allegedly posing as doctors using forged MBBS degreesCommissioner FDA reviews enforcement measuresKarnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplementsRoche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancerCDSCO tighten drug quality oversight as substandard and spurious medicine cases rise in five yearsPiramal Pharma Gets 3 USFDA Observations at US FacilityEli Lilly pauses Indian obesity awareness campaign after regulatory noticesKota: Uproar After 4 Women Die in Government Hospital; Relatives Refuse to Take BodiesICMR transfers three Indigenous Medical Technologies to Industry at National Technology Day 2026Will ‘Epidemic’ of Bridge Collapse in Bihar halt with new Minister in?Patient dies after oxygen supply stops in ambulanceIndiaAI, ICMR sign MoU to advance AI in healthcareIllegal drug manufacturing racket busted in Baddi areaUS FDA and Telangana DCA bolster global pharma safety at second regulatory forumNishant as Health Minister, Bihar is all set to witness a New Dawn of HealthcareSix Women Develop Serious Complications After C-SectionCracks Down on Pharma Biological Firm in Bagru; Labeling Violations, Unapproved Claims and Quality Lapses DetectedIndian Pharma Majors Plan to Invest in USEmcure Pharmaceuticals Q4 net profit rises 24% to ₹243.74 crFake Cancer Drug Racket: Delhi HC Grants Bail, Flags Gaps in ED ProbeA SSi Mantra fame Robotic Telesurgery Champion pulls off another Spectacular IntercontinentalNational Pharmaceutical Pricing Authority notifies retail price of 42 new drugsWorld’s First Malaria Treatment for Newborns and Young Infants Receives WHO PrequalificationFIR Lodged Against Pharmacist in Chandauli for Working Nearly 10 Years on Forged DocumentsLaughing all the Way to Health with Sir Ganga Ram HospitalSemaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik JonssonPak-made illegal cosmetics recovered from Itwari shopLicences of 20 medical stores suspended after inspectionsBain Capital sells nearly 1 pc stake in Emcure Pharma for Rs 289 croreSun Pharma to acquire U.S. firm Organon in $11.75 billion dealHP accounts for 47 inferior drugs in March alertCivil society group SAM calls for greater transparency involving clinical trialsDifferent packaging, typos expose fake Mounjaro racketTo Eat or not to Eat, if this Dilemma is ‘Eating’ you, ‘Eat’ this BookNCB Hyderabad raids illegal lab, seizes 69 kg of Alprazolam worth Rs 17.4 croreRajasthan Bans 7 Sub-Standard MedicinesONESOURCE’s partner receives USFDA tentative approval for Semaglutide InjectionAjanta Pharma gets USFDA Form 483 with five observations at Paithan plantObesity drug market to gain as Indians pop the pill and Chinese bring moreAurobindo Pharma Rs 800 Cr Buyback Opens Apr 23Boehringer Ingelheim launches AI centre for pharma research in LondonPharma exports rose 2% to over $31 billion in FY26 despite sharp decline in MarchCentre Urges States To Enforce Clinical Establishments Act & Standardise Hospital RatesPiramal, Ajinomoto team on ADC development and manufacturingAurobindo Pharma Gets USFDA Nod for Glycerol LiquidCancer cure must not be hostage to Big PharmaGLP-1 drugs emerge as a new option for Indian women bat­tling PCOSAurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral LiquidLegal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In IndiaPatna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS ActCOMT Inhibitors May Fuel Gut Bacteria That Degrade Levodopa In Parkinson’s PatientsDelhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One ArrestedFDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug DevelopmentIPC releases draft NFI-2026 to promote rational use of medicinesMoonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic SurgeryUS market to dent India pharma earnings even as domestic growth remains firmBiocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mgHealthcare, pharma sector to create 2-2.5 million new jobs by 2030Over 45% eye infection bacteria drug-resistant, study flags AMR threatLokayukta Police Launch Multi-City Raids on ADC; Rs 3.37 Crore in Disproportionate Assets Unearthed Across KarnatakaAlembic Pharma Gets USFDA Nod for DapagliflozinOn World Health Day ‘CAHO Na Patient Se Pyaar Hai’Supreme Court willing to understand Angst of Doctors regarding Consumer Protection ActAurobindo Pharma Board approves ₹800 cr share buyback planThree held for cheating SCB Hospital patients on promise of arranging bloodNATHEALTH resolves to evolve to fit The Bill of Viksit BharatCancer drug makers seek 50% price hike as platinum surge hits production viabilityCDRI’s new research hub in Lucknow to facilitate innovation in drug discovery & developmentDelhi Police busts racket diverting govt-supplied medicines for private sale; 3 heldNiti Aayog & DPIIT Decriminalize Med Device Penalties for Ease of BusinessLaser rescued an Imperiled Food Pipe in Sir Ganga Ram HospitalCentre gives custom cushion to supply strained Pharma, MedTech manufacturersDelhi man arrested for running online racket selling counterfeit Ayurvedic productsCustoms Duty Exemption on Petrochemicals, AiMeD welcomes but Dil ‘Mange More’Sir Ganga Ram Hospital Launches Dialysis Center in Gurgaon for advanced care
June 6, 2026

Cipla arm secures marketing rights for cancer drug in US

Drug major Cipla today said its subsidiary has secured rights from Hyderabad-based MSN Laboratories to market and distribute colon cancer treatment drug Capecitabine in the US market.

Cipla USA, Inc, a subsidiary of the company will be marketing the drug in strengths of 150 and 500 mg tablets.

The company’s product is generic equivalent of Genentech’s Xeloda.

Capecitabine tablets are indicated in patients with colon cancer and for the treatment of patients with metastatic breast cancer after failure of prior anthracycline-containing chemotherapy.

As per IQVIA (IMS Health) dat, Xeloda and its generic equivalents had sales of around USD 178 million in the US for 12-month period ending June 2018.

Shares of Cipla today ended 0.27 per cent up at Rs 620.90 on the BSE.

    • admin

    Related Posts

    KGMU prof suspended for forcing patients to buy meds from pvt store
    KGMU prof suspended for forcing patients to buy meds from pvt store

    Lucknow: Faculty member in the ophthalmology department of KGMU, Prof Sanjiv Gupta, was suspended on charges of prescribing medicines and lenses for cataract surgery that were available at a private…

    Continue reading
    CDSCO receives 1,387 adverse drug reaction reports in nine months of 2025
    CDSCO receives 1,387 adverse drug reaction reports in nine months of 2025

    New Delhi: The pharmacovigilance division of the Central drug regulator has received a total of 1,387 adverse reports, with the highest regarding fixed dose combinations (FDCs), and a total of…

    Continue reading

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    KGMU prof suspended for forcing patients to buy meds from pvt store

    KGMU prof suspended for forcing patients to buy meds from pvt store

    World Record in Robotic Tele-Surgery takes Intercontinental Leap of 20,000 Km

    World Record in Robotic Tele-Surgery takes Intercontinental Leap of 20,000 Km

    CDSCO receives 1,387 adverse drug reaction reports in nine months of 2025

    CDSCO receives 1,387 adverse drug reaction reports in nine months of 2025

    NGT issues notice to Himachal pharma unit over pollution, water diversion allegations

    NGT issues notice to Himachal pharma unit over pollution, water diversion allegations

    Zydus Semaglutide approval: Delhi HC directs CDSCO to decide on patient safety concerns

    Zydus Semaglutide approval: Delhi HC directs CDSCO to decide on patient safety concerns

    DGFT Fixes Six New Standard Input Output Norms (SIONs) for Pharmaceutical and Chemical Exports

    DGFT Fixes Six New Standard Input Output Norms (SIONs) for Pharmaceutical and Chemical Exports